Original study - ZZI 01/2009

Essential oils: antimicrobial effects and potential treatment options in dental implantology

12. Harkenthal M, Hausen BM, Reichling J: 1,2,4-Trihydroxy menthane, a contact allergen from oxidized Australian tea tree oil. Pharmazie 2000;55(2):153-154

13. Hart PH, Brand C, Carson CF, Riley TV, Prager RH, Finlay-Jones JJ: Terpinen-4-ol, the main component of the essential oil of Melaleuca alternifolia (tea tree oil), suppresses inflammatory mediator production by activated human monocytes. Inflamm Res 2000;49(11): 619-626

14. Hausen BM, Reichling J, Harkenthal M: Degradation products of monoterpenes are the sensitizing agents in tea tree oil. Am J Contact Dermat 1999; 10(2):68-77

15. Hinou JB, Harvala CE, Hinou EB: Antimicrobial activity screening of 32 common constituents of essential oils. Pharmazie 1989;44(4):302-303

16. Jandourek A, Vaishampayan JK, Vazquez JA: Efficacy of melaleuca oral solution for the treatment of fluconazole refractory oral candidiasis in AIDS patients. AIDS 1998;12(9):1033-1037

17. Juergens UR, Dethlefsen U, Steinkamp G, Gillissen A, Repges R, Vetter H: Anti-inflammatory activity of 1.8-cineol (eucalyptol) in bronchial asthma: a double-blind placebo-controlled trial. Respir Med 2003;97(3):250-256

18. May J, Chan CH, King A, Williams L, French GL: Time-kill studies of tea tree oils on clinical isolates. J Antimicrob Chemother 2000;45(5):639-643

19. Montanaro L, Campoccia D, Arciola CR: Advancements in molecular epidemiology of implant infections and future perspectives. Biomaterials 2007; 28(34):5155-5168

20. Pfaller MA, Diekema DJ, Gibbs DL, Newell VA, Nagy E, Dobiasova S, Rinaldi M, Barton R, Veselov A, the Global Antifungal Surveillance Group: Candida krusei, a multidrug-resistant opportunistic fungal pathogen: Geographic and temporal trends from the ARTEMIS DISK Antifungal Surveillance Program, 2001 to 2005. J Clin Microbiol 2008 Feb;46(2):515-521. Epub 2007 Dec 12

21. Reich E, Arweiler N, Benz C, Lynch E, Scholz V: Stellenwert des Chlorhexidins in der Implantatversorgung – Konsensuspapier. ZWR 2007;116:359-362

22. Schwarz F, Bieling K, Bonsmann M, Latz T, Becker J: Nonsurgical treatment of moderate and advanced periimplantitis lesions: a controlled clinical study. Clin Oral Investig 2006;10(4):279-288

23. Vilaplana J, Romaguera C: Allergic contact dermatitis due to eucalyptol in an anti-inflammatory cream. Contact Dermatitis 2000;43(2):118

24. Warnke PH, Sherry E, Russo PA, Acil Y, Wiltfang J, Sivananthan S et al.: Antibacterial essential oils in malodorous cancer patients: clinical observations in 30 patients. Phytomedicine 2006; 13(7):463-467

25. Wiltfang J, Schultze-Mosgau S, Nkenke E, Thorwarth M, Neukam FW, Schlegel KA: Onlay augmentation versus sinuslift procedure in the treatment of the severely resorbed maxilla: a 5-year comparative longitudinal study. Int J Oral Maxillofac Surg 2005;34(8): 885-889

26. Woollard AC, Tatham KC, Barker S: The influence of essential oils on the process of wound healing: a review of the current evidence. J Wound Care 2007; 16(6):255-257

Footnote

1 Department of Oral and Maxillofacial Surgery, University of Kiel, Germany

2 Faculty of Health Sciences and Medicine, Bond University, QLD, Gold Coast, Australia

3 Institute of Infection Medicine, University of Kiel, Germany

Übersetzung: LinguaDent

PAGE: 1 | 2 | 3 | 4 | 5